Lista de obras -

A dual regimen of ritonavir/darunavir plus dolutegravir for rescue or simplification of rescue therapy: 48 weeks' observational data.

artículo científico publicado en 2017

Adefovir and lamivudine in combination compared with adefovir monotherapy in HBeAg-negative adults with chronic hepatitis B virus infection and clinical or virologic resistance to lamivudine: a retrospective, multicenter, nonrandomized, open-label s

artículo científico publicado en 2008

An open-label, prospective, observational study of the incidence of coronary artery disease in patients with hiv infection receiving highly active antiretroviral therapy ⬇️

artículo científico publicado el 1 de septiembre de 2003

Baseline and Breakthrough Resistance Mutations in HCV Patients Failing DAAs

artículo científico publicado en 2017

Boceprevir or telaprevir in hepatitis C virus chronic infection: The Italian real life experience.

artículo científico publicado en 2016

Changes in circulation of B and non-B HIV strains: spotlight on a reference centre for infectious diseases in Northern Italy

artículo científico publicado en 2008

Consensus interferon for chronic hepatitis C patients with genotype 1 who failed to respond to, or relapsed after, interferon alpha-2b and ribavirin in combination: an Italian pilot study

artículo científico publicado en 2002

Correlation between FIB4, liver stiffness and metabolic parameters in patients with HIV and hepatitis C virus co-infection

artículo científico publicado en 2011

Development and persistence of DAA resistance associated mutations in patients failing HCV treatment

artículo científico publicado en 2015

Dolutegravir Plus Rilpivirine as a Switch Option in cART-Experienced Patients: 96-Week Data.

artículo científico publicado en 2018

Durability of dolutegravir plus boosted darunavir as salvage or simplification of salvage regimens in HIV-1 infected, highly treatment-experienced subjects

article

Early emergence of raltegravir resistance mutations in patients receiving HAART salvage regimens

artículo científico publicado en 2010

Efficacy and safety of sofosbuvir/simeprevir plus flat dose ribavirin in genotype 1 elderly cirrhotic patients: A real-life study

artículo científico publicado en 2016

Epicardial adipose tissue is related to carotid intima-media thickness and visceral adiposity in HIV-infected patients with highly active antiretroviral therapy-associated metabolic syndrome

artículo científico publicado en 2007

Epicardial fat thickness and nonalcoholic fatty liver disease in obese subjects

artículo científico publicado en 2013

Erratum to: Management of HCV infection in the penitentiary setting in the direct-acting antivirals era: practical recommendations from an expert panel.

artículo científico publicado en 2017

Good safety profile and efficacy of leucocyte interferon-alpha in combination with oral ribavirin in treatment-naive patients with chronic hepatitis C: a multicentre, randomised, controlled study.

artículo científico publicado en 2003

HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b.

artículo científico publicado en 2012

HIV infection and cancer in the era of highly active antiretroviral therapy (Review).

artículo científico publicado en 2007

Hepatitis C virus-related B cell subtypes in non Hodgkin's lymphoma

artículo científico publicado en 2011

High Efficacy and Safety of Flat-Dose Ribavirin Plus Sofosbuvir/Daclatasvir in Genotype 3 Cirrhotic Patients

scientific article published on 14 August 2019

Highly active antiretroviral therapy-associated metabolic syndrome and cardiovascular risk

artículo científico publicado en 2006

Human Immunodeficiency Virus-Associated Malignancies: A Therapeutic Update ⬇️

artículo científico publicado el 1 de marzo de 2012

Human immunodeficiency virus & cardiovascular risk ⬇️

artículo científico publicado el 1 de diciembre de 2011

Individualized treatment with combination of Peg-interferon alpha 2b and ribavirin in patients infected with HCV genotype 3.

artículo científico publicado en 2010

Kawasaki-like syndromes and other vasculitic syndromes in HIV-infected patients.

artículo científico publicado en 2003

Long term nucleotide and nucleoside analogs treatment in chronic hepatitis B HBeAg negative genotype D patients and risk for hepatocellular carcinoma

artículo científico publicado en 2014

Management of HCV infection in the penitentiary setting in the direct-acting antivirals era: practical recommendations from an expert panel

artículo científico publicado en 2016

Methadone and QT prolongation in HIV-infected patients

artículo científico publicado en 2004

NKp30 isoforms in patients with chronic hepatitis C virus infection

artículo científico publicado en 2015

Naturally occurring mutations to HCV protease inhibitors in treatment-naïve patients

artículo científico publicado en 2012

Naturally occurring resistance mutations to inhibitors of HCV NS5A region and NS5B polymerase in DAA treatment-naïve patients

artículo científico publicado en 2013

Ongoing change in the treatment of HIV-associated malignancies in the HAART era.

artículo científico publicado en 2009

Performance of Real-Time Strain Elastography, Transient Elastography, and Aspartate-to-Platelet Ratio Index in the Assessment of Fibrosis in Chronic Hepatitis C

scientific article published on 01 July 2012

Performance of liver stiffness measurements by transient elastography in chronic hepatitis.

artículo científico publicado en 2013

Recommendations for the prevention, diagnosis, and treatment of chronic hepatitis B and C in special population groups (migrants, intravenous drug users and prison inmates).

artículo científico publicado en 2011

Relation of epicardial fat and alanine aminotransferase in subjects with increased visceral fat.

artículo científico publicado en 2008

Relation of subepicardial adipose tissue to carotid intima-media thickness in patients with human immunodeficiency virus

artículo científico publicado en 2007

Retroperitoneal cryptococcoma in a case of disseminated cryptococcosis on antifungal maintenance therapy.

artículo científico publicado en 2011

Short versus standard treatment with pegylated interferon alfa-2A plus ribavirin in patients with hepatitis C virus genotype 2 or 3: the cleo trial

artículo científico publicado en 2010

Switch to Dolutegravir plus Rilpivirine Dual Therapy in cART-Experienced Subjects: An Observational Cohort

artículo científico publicado en 2016

Takotsubo-like left ventricular dysfunction in an HIV-infected patient

artículo científico publicado en 2006

The pavia consensus statement

artículo científico publicado en 2003

Treatment of hepatitis C virus carriers with persistently normal alanine aminotransferase levels with peginterferon alpha-2a and ribavirin: a multicentric study.

artículo científico publicado en 2009

Treatment with direct-acting antivirals in a multicenter cohort of HCV-infected inmates in Italy

article

Lista de obras de

A dual regimen of ritonavir/darunavir plus dolutegravir for rescue or simplification of rescue therapy: 48 weeks' observational data.

Adefovir and lamivudine in combination compared with adefovir monotherapy in HBeAg-negative adults with chronic hepatitis B virus infection and clinical or virologic resistance to lamivudine: a retrospective, multicenter, nonrandomized, open-label s

An open-label, prospective, observational study of the incidence of coronary artery disease in patients with hiv infection receiving highly active antiretroviral therapy ⬇️

Baseline and Breakthrough Resistance Mutations in HCV Patients Failing DAAs

Boceprevir or telaprevir in hepatitis C virus chronic infection: The Italian real life experience.

Changes in circulation of B and non-B HIV strains: spotlight on a reference centre for infectious diseases in Northern Italy

Consensus interferon for chronic hepatitis C patients with genotype 1 who failed to respond to, or relapsed after, interferon alpha-2b and ribavirin in combination: an Italian pilot study

Correlation between FIB4, liver stiffness and metabolic parameters in patients with HIV and hepatitis C virus co-infection

Development and persistence of DAA resistance associated mutations in patients failing HCV treatment

Dolutegravir Plus Rilpivirine as a Switch Option in cART-Experienced Patients: 96-Week Data.

Durability of dolutegravir plus boosted darunavir as salvage or simplification of salvage regimens in HIV-1 infected, highly treatment-experienced subjects

Early emergence of raltegravir resistance mutations in patients receiving HAART salvage regimens

Efficacy and safety of sofosbuvir/simeprevir plus flat dose ribavirin in genotype 1 elderly cirrhotic patients: A real-life study

Epicardial adipose tissue is related to carotid intima-media thickness and visceral adiposity in HIV-infected patients with highly active antiretroviral therapy-associated metabolic syndrome

Epicardial fat thickness and nonalcoholic fatty liver disease in obese subjects

Erratum to: Management of HCV infection in the penitentiary setting in the direct-acting antivirals era: practical recommendations from an expert panel.

Good safety profile and efficacy of leucocyte interferon-alpha in combination with oral ribavirin in treatment-naive patients with chronic hepatitis C: a multicentre, randomised, controlled study.

HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b.

HIV infection and cancer in the era of highly active antiretroviral therapy (Review).

Hepatitis C virus-related B cell subtypes in non Hodgkin's lymphoma

High Efficacy and Safety of Flat-Dose Ribavirin Plus Sofosbuvir/Daclatasvir in Genotype 3 Cirrhotic Patients

Highly active antiretroviral therapy-associated metabolic syndrome and cardiovascular risk

Human Immunodeficiency Virus-Associated Malignancies: A Therapeutic Update ⬇️

Human immunodeficiency virus &amp; cardiovascular risk ⬇️

Individualized treatment with combination of Peg-interferon alpha 2b and ribavirin in patients infected with HCV genotype 3.

Kawasaki-like syndromes and other vasculitic syndromes in HIV-infected patients.

Long term nucleotide and nucleoside analogs treatment in chronic hepatitis B HBeAg negative genotype D patients and risk for hepatocellular carcinoma

Management of HCV infection in the penitentiary setting in the direct-acting antivirals era: practical recommendations from an expert panel

Methadone and QT prolongation in HIV-infected patients

NKp30 isoforms in patients with chronic hepatitis C virus infection

Naturally occurring mutations to HCV protease inhibitors in treatment-naïve patients

Naturally occurring resistance mutations to inhibitors of HCV NS5A region and NS5B polymerase in DAA treatment-naïve patients

Ongoing change in the treatment of HIV-associated malignancies in the HAART era.

Performance of Real-Time Strain Elastography, Transient Elastography, and Aspartate-to-Platelet Ratio Index in the Assessment of Fibrosis in Chronic Hepatitis C

Performance of liver stiffness measurements by transient elastography in chronic hepatitis.

Recommendations for the prevention, diagnosis, and treatment of chronic hepatitis B and C in special population groups (migrants, intravenous drug users and prison inmates).

Relation of epicardial fat and alanine aminotransferase in subjects with increased visceral fat.

Relation of subepicardial adipose tissue to carotid intima-media thickness in patients with human immunodeficiency virus

Retroperitoneal cryptococcoma in a case of disseminated cryptococcosis on antifungal maintenance therapy.

Short versus standard treatment with pegylated interferon alfa-2A plus ribavirin in patients with hepatitis C virus genotype 2 or 3: the cleo trial

Switch to Dolutegravir plus Rilpivirine Dual Therapy in cART-Experienced Subjects: An Observational Cohort

Takotsubo-like left ventricular dysfunction in an HIV-infected patient

The pavia consensus statement

Treatment of hepatitis C virus carriers with persistently normal alanine aminotransferase levels with peginterferon alpha-2a and ribavirin: a multicentric study.

Treatment with direct-acting antivirals in a multicenter cohort of HCV-infected inmates in Italy

Human immunodeficiency virus & cardiovascular risk ⬇️